Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12545934-B2

Patent

Publication Date

2026-02-10

Expiration Date


Abstract

The present disclosure relates to methods for producing oxygenated terpenoids, and preparation of compositions and formulations thereof. Polynucleotides, derivative enzymes, and host cells for use in such methods are also provided.

Core Innovation

The invention provides a method for producing oxygenated terpenes by contacting valencene with Stevia rebaudiana Kaurene Oxidase (SrKO) or an SrKO derivative having valencene-oxidizing activity in an in vitro or in vivo system. The resulting oxygenated product comprises nootkatone, ́-nootkatol, and ̂-nootkatol. The obtained formulation is incorporated into a consumer product, an industrial product, a flavor product, a fragrance product, a cosmetic product, a cleaning product, a detergent product, a soap product, or a pest control product.

Engineered valencene oxidase variants, membrane-anchor designs, host-cell pathways, enzyme partners, and expression constructs provide improved oxygenated-product titers, including approximately 1.3-fold titer improvements with SrCPR3 and AaCPR. Four alcohol dehydrogenase orthologs that convert ̂-nootkatol provide more than threefold increases in nootkatone titers. Sequence alignments comparing SrKO with related enzyme variants identify conserved and differing residues relevant to valencene oxidation.

Claims Coverage

The claim coverage identifies one independent claim directed to producing an oxygenated valencene formulation and incorporating it into a specified product category, comprising two inventive features.

Production of an oxygenated valencene product

Obtaining a formulation by contacting valencene with Stevia rebaudiana Kaurene Oxidase (SrKO) or an SrKO derivative comprising a sequence having at least 70% sequence identity to SEQ ID NO: 37, SEQ ID NO: 38, or SEQ ID NO: 55, and having valencene-oxidizing activity in an in vitro or in vivo system to produce an oxygenated product comprising nootkatone, ́-nootkatol, and ̂-nootkatol.

Incorporation into a specified product

Incorporating the formulation into a consumer product, an industrial product, a flavor product, a fragrance product, a cosmetic product, a cleaning product, a detergent product, a soap product, or a pest control product.

The independent claim combines the enzymatic production of an oxygenated formulation comprising nootkatone, ́-nootkatol, and ̂-nootkatol with the incorporation of that formulation into one of the specified product categories.

Stated Advantages

Engineered valencene oxidase variants and membrane-anchor designs improve oxygenated-product titers.

SrCPR3 and AaCPR provide approximately 1.3-fold titer improvements.

Four alcohol dehydrogenase orthologs increase nootkatone titers by more than threefold by converting ̂-nootkatol.

The production process forms multiple oxygenated products, including nootkatone, ́-nootkatol, and ̂-nootkatol.

Documented Applications

The formulation is incorporated into a consumer product, industrial product, flavor product, fragrance product, cosmetic product, cleaning product, detergent product, soap product, or pest control product, with flavor products including beverages, chewing gum, candy, natural flavor, artificial flavor, and flavor additives.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.